VEGFA and age-related macular degeneration: This study investigates whether visual and anatomic outcomes in eyes with neovascular age-related macular degeneration (AMD) initiating anti–vascular endothelial growth factor (VEGF) treatment are associated with fluctuations in retinal thickness.